# Efficacy of Verciguat in TR and RV Failure

> **NCT07668739** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Daejeon St. Mary's hospital** · enrollment: 100 (estimated)

## Conditions studied

- HFrEF
- Tricuspid Regurgitation (TR)

## Interventions

- **DRUG:** Vericiguat

## Key facts

- **NCT ID:** NCT07668739
- **Lead sponsor:** Daejeon St. Mary's hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2028-05-31
- **Final completion:** 2028-05-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-06-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07668739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07668739, "Efficacy of Verciguat in TR and RV Failure". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07668739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*